UCB9608 is a potent and selective oral inhibitor of PI4KIIIbeta (IC50 = 11 nM), demonstrating high selectivity against related PI3KC2 isoforms. This tool compound is used in research to investigate phosphoinositide signaling in cellular models and has been evaluated in studies exploring its potential in vivo pharmacological effects.